Digestive and Liver Disease
Volume 42, Issue 4 , Pages 305-306 , April 2010

Author's reply to Comment on “Treating chronic hepatitis C in recovering opiate addicts: Yes, we can”

References 

  1. Guadagnino V, Trotta MP, Montesano F, et al. Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes. Addiction. 2007;102:423–431
  2. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958–965
  3. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–982
  4. Mauss S, Berger F, Goelz J, et al. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology. 2004;40:120–124
  5. Sylvestre DL. Approaching treatment for hepatitis C virus infection in substance users. Clin Infect Dis. 2005;41(Suppl. 1):S79–S82

PII: S1590-8658(09)00326-0

doi: 10.1016/j.dld.2009.07.016

Digestive and Liver Disease
Volume 42, Issue 4 , Pages 305-306 , April 2010